Presbyterian is offering monoclonal antibody therapy for the treatment of COVID-19 non-hospitalized patients, who have mild to moderate disease, and who are at high risk of progressing to severe COVID-19 and/or hospitalization. Bamlanivimab and Casirivimab/Imdevimab are unapproved monoclonal antibody therapies under FDA Emergency Use Authorization.
This therapy is available only through a provider referral. If you are a patient and are interested in this therapy, you will need to contact your provider’s office.
Which patients are eligible for this therapy?
Adult and pediatric patients with positive results of direct SARS-CoV-2 viral testing (PCR or antigen testing) who are 12 years of age and older, weigh at least 40 kg, and who are at
high risk for progressing to severe COVID-19 and/or hospitalization.
The monoclonal antibody therapy (either bamlanivimab or casirivimab/imdevimab) should be administered as soon as possible after positive SARS-CoV-2 and
within 10 days of symptom onset. Patients are not eligible for treatment if > 10 days from symptom onset. Treatment generally takes two to three hours in one single session. Not all infusion locations are able to facilitate pediatric infusions; please call your local site to confirm.
Patient
must meet at least one
high risk criterion for treatment eligibility:
-
Body mass index (BMI) ≥35
-
Chronic kidney disease
-
Diabetes
-
Immunosuppressive disease
-
Currently receiving immunosuppressive treatment
-
≥65 years of age
-
≥55 years of age
AND have at least one of the following:
-
Cardiovascular disease
-
Hypertension
-
Chronic obstructive pulmonary disease/other chronic respiratory disease.
-
12 – 17 years of age
AND have at least one of the following:
-
BMI ≥85th percentile for their age and gender based on
CDC growth charts
-
Sickle cell disease
-
Congenital or acquired heart disease
-
Neurodevelopmental disorders, for example, cerebral palsy
-
A medical-related technological dependence, for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19)
-
Asthma, reactive airway or other chronic respiratory disease that requires daily medication for control.
Which patients are NOT eligible for this therapy?
-
those previously hospitalized due to COVID-19
-
those who require oxygen therapy due to COVID-19
-
those who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related co-morbidity
How do I refer a patient for this therapy?
Any New Mexico physician or advanced practice clinician can refer a patient for monoclonal antibody therapy.
Once you have determined that your patient is eligible for treatment:
-
Download, print, and complete this two-page referral form
Provider Referral -
Fax the referral form and other required documents, to Presbyterian Infusion Services at 505-355-7158.
Other required documents include:
-
Fax coversheet from referring provider’s primary practice
-
Patient demographics (patient name, DOB, address, insurance, primary language)
-
Copy of most recent clinical encounter (e.g. history and physical, progress note, telephone note, video appointment note)
-
Copy of positive COVID-19 test result. Test result may be sent from provider’s office or patient may present hard copy, text, or email verification at time of appointment.
PLEASE NOTE: Treatment will not be provided unless positive COVID-19 test result is confirmed.
If you have questions regarding eligibility of your patient, please call
505-291-2626.
Where can my patients get this treatment?
There are seven locations statewide. Hours are generally 8:00 am–4:30 pm most days of the week, including weekends. Please check the individual location for specific times.
Presbyterian Kaseman Hospital
8300 Constitution Ave. NE
Albuquerque NM 87110
505-291-2626
Plains Regional Medical Center
2100 N. Martin Luther King Jr. Blvd.
Clovis NM 88101
575-769-5857
Presbyterian Espanola Hospital
1010 Spruce St.
Espanola NM 87532
505-367-7257
Lincoln County Medical Center
211 Sudderth Dr.
Ruidoso NM 88345
575-630-5257
Presbyterian Santa Fe Medical Center
4801 Beckner Rd.
Santa Fe NM 87507
505-772-5857
Socorro General Hospital
1202 Highway 60 West
Socorro NM 87801
575-835-8757
Dr. Dan C. Trigg Memorial Hospital
301 E. Miel de Luna
Tucumcari NM 88401
575-461-7257
Questions about the Monoclonal Antibody Therapies?
Bamlanivimab
For Providers
For Patients
Para los pacientes
Casirivimab/Imdevimab
For Providers
For Patients
Para los pacientes